| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 09/26/2018 |
3. Issuer Name and Ticker or Trading Symbol
SUTRO BIOPHARMA INC [ STRO ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| No securities beneficially held | 0 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Common Stock Warrant (right to buy) | (1) | (1) | Common Stock | 314 | 5.808(2) | D | |
| Stock Option (right to buy Common Stock) | (3) | 03/24/2019 | Common Stock | 3,030 | 5.09 | D | |
| Stock Option (right to buy Common Stock) | (3) | 09/08/2019 | Common Stock | 826 | 5.09 | D | |
| Stock Option (right to buy Common Stock) | (3) | 02/08/2021 | Common Stock | 4,132 | 4.36 | D | |
| Stock Option (right to buy Common Stock) | (3) | 04/17/2022 | Common Stock | 4,545 | 4.36 | D | |
| Stock Option (right to buy Common Stock) | (3) | 09/19/2022 | Common Stock | 2,617 | 4.36 | D | |
| Stock Option (right to buy Common Stock) | (3) | 02/13/2023 | Common Stock | 578 | 5.81 | D | |
| Stock Option (right to buy Common Stock) | (3) | 02/13/2023 | Common Stock | 873 | 5.81 | D | |
| Stock Option (right to buy Common Stock) | (3) | 02/26/2024 | Common Stock | 2,124 | 5.81 | D | |
| Stock Option (right to buy Common Stock) | (3) | 02/26/2024 | Common Stock | 3,540 | 5.81 | D | |
| Stock Option (right to buy Common Stock) | (4) | 09/27/2025 | Common Stock | 1,456 | 11.98 | D | |
| Stock Option (right to buy Common Stock) | (3) | 09/27/2025 | Common Stock | 2,427 | 11.98 | D | |
| Explanation of Responses: |
| 1. The warrant is exercisable at any time at the holder's election on a one-for one basis and automatically terminates on the completion of the issuer's initial public offering if not earlier exercised. |
| 2. The warrant has a net exercise provision under which the holder, in lieu of paying the exercise price in cash, can surrender the warrant and receive a net number of shares of common stock based on the fair market value of such stock at the time of exercise, after deducting the aggregate exercise price. |
| 3. The option is fully vested. |
| 4. The option vests as to 2.0833% of the total shares monthly, beginning on October 15, 2015, with 100% of the total shares vested and exercisable on September 15, 2019, subject to the reporting person's provision of service to the issuer on each vesting date. |
| Remarks: |
| /s/ Edward C. Albini as attorney-in-fact for Daniel H. Petree | 09/26/2018 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||